Curis, Inc CRIS

Erictaylor

Although it had nic rip off support of a larger pattern with another test of the mid term downward resiatnce I am looking to potentially scoop some up. I really want to see how we react at this 7.60$ level holding as support. Might be worth a buy attempt. Targets of 10$+ howver the Key breakout level isn’t until we did suppprt above 8.05$. Therefor that’s the...

vgandhi23

The technicals are in favor for a bullish run. with a major gap to fill near 11.94. I think we see a positive run in the coming days

chrisw1224

LOWER HIGH and LOWER LOW.... see that and bounce!!!

cheatcountry

This is my top 10 estimates for the highs of the day on Monday (6/12/2021) according to my AI program and for those users that have been following my ai idea updates, I have improved the ai quite a bit to provide much more accurate results and I have implemented a scoring system that ranges from +30 to -30 and this is essentially the AI confidence that the...

ewhite41

If we hold, we have a double bottom in play. This could lead to filling the gap that has occurred. Look for institutions to treat this as the Demand zone. The recent sell off was the supply zone.

chrisw1224

good trade buy em... Biotwch breakthrough

BradWeber82

Not much to say about this. Prime example of what happens when top resistance breaks. NO POSITION.

TheDreIsReal

Looks like a hold to me.

TheDreIsReal

CRIS strength/resistance

mhasky62441

Touching a past support level and just touching the regression line. I'm kind of at the outlook of CRIS beginning to climb.

AlenCiken

Curis Announces Positive Preliminary Data from Ongoing Phase 1 Study of CA-4948 Monotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia and Myelodysplastic Syndromes. Key findings include: - Marrow blast reductions observed in all evaluable patients (6 patients). - 6 of 7 patients enrolled remain on study. - Patients enrolled experienced a...

Benji-13

Curis Announces Positive Preliminary Data from Ongoing Phase 1 Study of CA-4948 Monotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia and Myelodysplastic Syndromes 1% CAPITAL

growerik

Curis skyrockets 448% after encouraging phase 1 data for leukemia treatment! BE CAREFUL here, this is a speculative play. I got a couple batches of shares. Do your own due diligence, your risk is 100% your responsibility. You win some or you learn some. Consider being charitable with some of your profit to help humankind. Small incremental steps work : If you...

UncleBeeB

request for tonboga

RocketTickers

CRIS: Curis, Inc. 2020-12-08 07:00:00 Curis Announces Positive Preliminary Data from Ongoing Phase 1 Study of CA-4948 Monotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia and Myelodysplastic Syndromes

st0nkz

Do your research on $TRIL and $FTSY. You'll see why I'm excited to invest in this company.

banjo_nz

NASDAQ:CRIS DISCLOSURE: II've been a long follower of CURIS since two years ago and experienced an abysmal loss last year because I got married with this stock. LOL. Key fundamentals: $17.5 million shares offering at $1.24 on June 12, 2020. FDA clearance of IND application for CI-8993 on June 10, 2020 and the stock sky rocketed from .86c to $3.86 range...

02:56

InvestSmartWAAS

I made 3 successful trades and I called it quits